skip to main content

Device Therapy Timeline in HF — EECC MCQ

Instant feedback + full explanation. One question, done properly.

EasyHeart FailureDevice Therapy Timeline in HFEECC

A 60-year-old man with HFrEF asks about the optimal timing of device therapy in the HF management timeline. When should ICD and CRT be considered relative to GDMT initiation?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: EGDMT should be initiated first and uptitrated over at least 3 months; LVEF is then reassessed — if LVEF remains ≤35% with QRS ≥130 ms, CRT should be considered; if LVEF ≤35% without CRT indication, ICD should be considered

The ESC 2023 HF Guidelines recommend a stepwise approach: (1) Start and uptitrate all four pillars of GDMT (ACEi/ARNI + beta-blocker + MRA + SGLT2i) simultaneously with close follow-up (STRONG-HF approach); (2) After ≥3 months of optimal GDMT, reassess LVEF; (3) If LVEF remains ≤35% and QRS ≥130 ms (especially ≥150 ms with LBBB), CRT-D is indicated; (4) If LVEF remains ≤35% without CRT indication (narrow QRS, non-LBBB pattern), primary prevention ICD is indicated. This sequence ensures that patients whose LVEF recovers above 35% with GDMT avoid unnecessary device implantation. During the GDMT optimisation period, a WCD may provide interim SCD protection if risk is high.

Reference: ESC (2023): HF Guidelines; ESC (2021): Pacing/CRT Guidelines